Julie Ann Justo, PharmD, MS, FIDSA, BCPS-AQ ID

Clinical Associate Professor
University of South Carolina College of Pharmacy

Disclosure(s): bioMerieux: Honoraria, Honoraria, Honoraria, Honoraria; Entasis Therapeutics: Advisor/Consultant, Advisor/Consultant, Advisor/Consultant, Advisor/Consultant; Gilead Sciences: Advisor/Consultant, Advisor/Consultant, Advisor/Consultant, Advisor/Consultant; Merck & Co: Advisor/Consultant, Advisor/Consultant, Advisor/Consultant, Advisor/Consultant; Shionogi: Advisor/Consultant, Advisor/Consultant; Shionogi Inc.: Advisor/Consultant, Advisor/Consultant; Spero Therapeutics: Honoraria, Honoraria, Honoraria, Honoraria; Vaxart: Stocks/Bonds, Stocks/Bonds

Poster(s):

• 408 - Benchmarking the Use of New β-lactams Utilizing a Novel Metric of Microbiological Burden
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 409 - Temporal Trends in Antibiotic Use of New β-lactams for Gram-Negative Bacteria with Difficult-to-Treat Resistance in the Southeastern United States
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 1841 - Incidence and Predictors of Complications in Gram Negative Bloodstream Infection
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET